![Sandoz Losartan Potassium & Ezetimibe Drug Recall [US]](https://livingsafelyrecalls.files.wordpress.com/2019/08/11977-sandozlosartanpotassiumezetimibedrugs.jpg?w=116&h=150)
Click to enlarge

US/Washington: Sandoz Inc., a Princeton, New Jersey establishment, recalls an estimated 636,000 Losartan Potassium Prescription Drug and Ezetimibe Prescription Drug Bottles due to suspected failure to meet child-resistant closure requirements as required by the US Poison Prevention Packaging Act and consequential risk of choking, ingestion and poisoning, all serious health and safety hazards.
CPSC: http://ht.ly/2wC230proqE
Direct link: https://www.cpsc.gov/Recalls/2019/Sandoz-Recalls-Losartan-Potassium-and-Ezetimibe-Prescription-Drug-Bottles-Due-to-Failure-to-Meet-ChildResistant-Closure-Requirements
Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports this recall involves Bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain identified batch/lot numbers.
Continue reading →
Like this:
Like Loading...
Filed under: Drugs, Ingestion hazard, Labeling or regulatory issues, Medical / Veterinary, US CPSC | Tagged: bacterial contamination, CPSC, CPSC recall number: 19-194, Ezetimibe, ingestion hazard, ingestion hazards, Losartan Potassium, Novartis, Recalls Direct RIN: 11977-2019, Sandoz, US Consumer Product Safety Commission | Leave a comment »